Survey of the models and examination of organisational approaches, data sources to stratify the population into risk groups and assessment of data on feasibility, transferability and implementation of tools addressing screening facilitators and barriers will be conducted. Clinical questions for guidelines will be prioritized, including benefits and harms through implementation research, and definitions of cost-effectiveness. Other activities will include coordination of data analysis plans from pilot studies with 2 approaches: individual risk assessment and screening history; analysis of European guidelines for alignment or need for new recommendations; and development of a toolbox for implementation strategies based on existing recommendations, and findings from this task, WP4, WP6 and WP10, to support national/local decision making.
This task will be led by CPO, Italy.